ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical 3D Bioprinting Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-7I10823
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medical 3D Bioprinting Market Research Report 2022
BUY CHAPTERS

Global Medical 3D Bioprinting Market Research Report 2025

Code: QYRE-Auto-7I10823
Report
February 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
3D Systems
GE Healthcare
Exone
Electro Optical Systems
Renishaw
Stratasys Ltd
EnvisionTEC Inc
Cyfuse Biomedical
Formlabs
Organovo Holdings
Allevi
Advanced Solutions
Aspect Biosystems
Cellink AB
GeSIM
Bio3D Technologies
Regenovo Biotechnology
Optomec Inc
Mecuris GmbH
BIGREP
Fluicell

Medical 3D Bioprinting Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Medical 3D Bioprinting Market

Medical 3D Bioprinting Market

The global market for Medical 3D Bioprinting was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical 3D Bioprinting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical 3D Bioprinting.
The Medical 3D Bioprinting market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical 3D Bioprinting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical 3D Bioprinting companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Medical 3D Bioprinting Market Report

Report Metric Details
Report Name Medical 3D Bioprinting Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • SLA
  • FDM
  • LOM
  • Others
Segment by Application
  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 3D Systems, GE Healthcare, ExOne, Electro Optical Systems, Renishaw, Stratasys, EnvisionTEC, Cyfuse Biomedical, Formlabs, Organovo Holdings, Allevi, Advanced Solutions, Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies, Regenovo Biotechnology, Optomec, Mecuris, Fluicell, BigRep
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Medical 3D Bioprinting company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Medical 3D Bioprinting Market report?

Ans: The main players in the Medical 3D Bioprinting Market are 3D Systems, GE Healthcare, ExOne, Electro Optical Systems, Renishaw, Stratasys, EnvisionTEC, Cyfuse Biomedical, Formlabs, Organovo Holdings, Allevi, Advanced Solutions, Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies, Regenovo Biotechnology, Optomec, Mecuris, Fluicell, BigRep

What are the Application segmentation covered in the Medical 3D Bioprinting Market report?

Ans: The Applications covered in the Medical 3D Bioprinting Market report are Medical Device Manufacturers, Pharmaceutical Companies, Others

What are the Type segmentation covered in the Medical 3D Bioprinting Market report?

Ans: The Types covered in the Medical 3D Bioprinting Market report are SLA, FDM, LOM, Others

Recommended Reports

Medical 3D Printing

Dental 3D Solutions

Medical Imaging & Scanners

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical 3D Bioprinting Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 SLA
1.2.3 FDM
1.2.4 LOM
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medical 3D Bioprinting Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Device Manufacturers
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical 3D Bioprinting Market Perspective (2020-2031)
2.2 Global Medical 3D Bioprinting Growth Trends by Region
2.2.1 Global Medical 3D Bioprinting Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medical 3D Bioprinting Historic Market Size by Region (2020-2025)
2.2.3 Medical 3D Bioprinting Forecasted Market Size by Region (2026-2031)
2.3 Medical 3D Bioprinting Market Dynamics
2.3.1 Medical 3D Bioprinting Industry Trends
2.3.2 Medical 3D Bioprinting Market Drivers
2.3.3 Medical 3D Bioprinting Market Challenges
2.3.4 Medical 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical 3D Bioprinting Players by Revenue
3.1.1 Global Top Medical 3D Bioprinting Players by Revenue (2020-2025)
3.1.2 Global Medical 3D Bioprinting Revenue Market Share by Players (2020-2025)
3.2 Global Medical 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Medical 3D Bioprinting Revenue
3.4 Global Medical 3D Bioprinting Market Concentration Ratio
3.4.1 Global Medical 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical 3D Bioprinting Revenue in 2024
3.5 Global Key Players of Medical 3D Bioprinting Head office and Area Served
3.6 Global Key Players of Medical 3D Bioprinting, Product and Application
3.7 Global Key Players of Medical 3D Bioprinting, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical 3D Bioprinting Breakdown Data by Type
4.1 Global Medical 3D Bioprinting Historic Market Size by Type (2020-2025)
4.2 Global Medical 3D Bioprinting Forecasted Market Size by Type (2026-2031)
5 Medical 3D Bioprinting Breakdown Data by Application
5.1 Global Medical 3D Bioprinting Historic Market Size by Application (2020-2025)
5.2 Global Medical 3D Bioprinting Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Medical 3D Bioprinting Market Size (2020-2031)
6.2 North America Medical 3D Bioprinting Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medical 3D Bioprinting Market Size by Country (2020-2025)
6.4 North America Medical 3D Bioprinting Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical 3D Bioprinting Market Size (2020-2031)
7.2 Europe Medical 3D Bioprinting Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medical 3D Bioprinting Market Size by Country (2020-2025)
7.4 Europe Medical 3D Bioprinting Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical 3D Bioprinting Market Size (2020-2031)
8.2 Asia-Pacific Medical 3D Bioprinting Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2020-2025)
8.4 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical 3D Bioprinting Market Size (2020-2031)
9.2 Latin America Medical 3D Bioprinting Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medical 3D Bioprinting Market Size by Country (2020-2025)
9.4 Latin America Medical 3D Bioprinting Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical 3D Bioprinting Market Size (2020-2031)
10.2 Middle East & Africa Medical 3D Bioprinting Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2020-2025)
10.4 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3D Systems
11.1.1 3D Systems Company Details
11.1.2 3D Systems Business Overview
11.1.3 3D Systems Medical 3D Bioprinting Introduction
11.1.4 3D Systems Revenue in Medical 3D Bioprinting Business (2020-2025)
11.1.5 3D Systems Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Medical 3D Bioprinting Introduction
11.2.4 GE Healthcare Revenue in Medical 3D Bioprinting Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 ExOne
11.3.1 ExOne Company Details
11.3.2 ExOne Business Overview
11.3.3 ExOne Medical 3D Bioprinting Introduction
11.3.4 ExOne Revenue in Medical 3D Bioprinting Business (2020-2025)
11.3.5 ExOne Recent Development
11.4 Electro Optical Systems
11.4.1 Electro Optical Systems Company Details
11.4.2 Electro Optical Systems Business Overview
11.4.3 Electro Optical Systems Medical 3D Bioprinting Introduction
11.4.4 Electro Optical Systems Revenue in Medical 3D Bioprinting Business (2020-2025)
11.4.5 Electro Optical Systems Recent Development
11.5 Renishaw
11.5.1 Renishaw Company Details
11.5.2 Renishaw Business Overview
11.5.3 Renishaw Medical 3D Bioprinting Introduction
11.5.4 Renishaw Revenue in Medical 3D Bioprinting Business (2020-2025)
11.5.5 Renishaw Recent Development
11.6 Stratasys
11.6.1 Stratasys Company Details
11.6.2 Stratasys Business Overview
11.6.3 Stratasys Medical 3D Bioprinting Introduction
11.6.4 Stratasys Revenue in Medical 3D Bioprinting Business (2020-2025)
11.6.5 Stratasys Recent Development
11.7 EnvisionTEC
11.7.1 EnvisionTEC Company Details
11.7.2 EnvisionTEC Business Overview
11.7.3 EnvisionTEC Medical 3D Bioprinting Introduction
11.7.4 EnvisionTEC Revenue in Medical 3D Bioprinting Business (2020-2025)
11.7.5 EnvisionTEC Recent Development
11.8 Cyfuse Biomedical
11.8.1 Cyfuse Biomedical Company Details
11.8.2 Cyfuse Biomedical Business Overview
11.8.3 Cyfuse Biomedical Medical 3D Bioprinting Introduction
11.8.4 Cyfuse Biomedical Revenue in Medical 3D Bioprinting Business (2020-2025)
11.8.5 Cyfuse Biomedical Recent Development
11.9 Formlabs
11.9.1 Formlabs Company Details
11.9.2 Formlabs Business Overview
11.9.3 Formlabs Medical 3D Bioprinting Introduction
11.9.4 Formlabs Revenue in Medical 3D Bioprinting Business (2020-2025)
11.9.5 Formlabs Recent Development
11.10 Organovo Holdings
11.10.1 Organovo Holdings Company Details
11.10.2 Organovo Holdings Business Overview
11.10.3 Organovo Holdings Medical 3D Bioprinting Introduction
11.10.4 Organovo Holdings Revenue in Medical 3D Bioprinting Business (2020-2025)
11.10.5 Organovo Holdings Recent Development
11.11 Allevi
11.11.1 Allevi Company Details
11.11.2 Allevi Business Overview
11.11.3 Allevi Medical 3D Bioprinting Introduction
11.11.4 Allevi Revenue in Medical 3D Bioprinting Business (2020-2025)
11.11.5 Allevi Recent Development
11.12 Advanced Solutions
11.12.1 Advanced Solutions Company Details
11.12.2 Advanced Solutions Business Overview
11.12.3 Advanced Solutions Medical 3D Bioprinting Introduction
11.12.4 Advanced Solutions Revenue in Medical 3D Bioprinting Business (2020-2025)
11.12.5 Advanced Solutions Recent Development
11.13 Aspect Biosystems
11.13.1 Aspect Biosystems Company Details
11.13.2 Aspect Biosystems Business Overview
11.13.3 Aspect Biosystems Medical 3D Bioprinting Introduction
11.13.4 Aspect Biosystems Revenue in Medical 3D Bioprinting Business (2020-2025)
11.13.5 Aspect Biosystems Recent Development
11.14 CELLINK
11.14.1 CELLINK Company Details
11.14.2 CELLINK Business Overview
11.14.3 CELLINK Medical 3D Bioprinting Introduction
11.14.4 CELLINK Revenue in Medical 3D Bioprinting Business (2020-2025)
11.14.5 CELLINK Recent Development
11.15 GeSiM
11.15.1 GeSiM Company Details
11.15.2 GeSiM Business Overview
11.15.3 GeSiM Medical 3D Bioprinting Introduction
11.15.4 GeSiM Revenue in Medical 3D Bioprinting Business (2020-2025)
11.15.5 GeSiM Recent Development
11.16 Bio3D Technologies
11.16.1 Bio3D Technologies Company Details
11.16.2 Bio3D Technologies Business Overview
11.16.3 Bio3D Technologies Medical 3D Bioprinting Introduction
11.16.4 Bio3D Technologies Revenue in Medical 3D Bioprinting Business (2020-2025)
11.16.5 Bio3D Technologies Recent Development
11.17 Regenovo Biotechnology
11.17.1 Regenovo Biotechnology Company Details
11.17.2 Regenovo Biotechnology Business Overview
11.17.3 Regenovo Biotechnology Medical 3D Bioprinting Introduction
11.17.4 Regenovo Biotechnology Revenue in Medical 3D Bioprinting Business (2020-2025)
11.17.5 Regenovo Biotechnology Recent Development
11.18 Optomec
11.18.1 Optomec Company Details
11.18.2 Optomec Business Overview
11.18.3 Optomec Medical 3D Bioprinting Introduction
11.18.4 Optomec Revenue in Medical 3D Bioprinting Business (2020-2025)
11.18.5 Optomec Recent Development
11.19 Mecuris
11.19.1 Mecuris Company Details
11.19.2 Mecuris Business Overview
11.19.3 Mecuris Medical 3D Bioprinting Introduction
11.19.4 Mecuris Revenue in Medical 3D Bioprinting Business (2020-2025)
11.19.5 Mecuris Recent Development
11.20 Fluicell
11.20.1 Fluicell Company Details
11.20.2 Fluicell Business Overview
11.20.3 Fluicell Medical 3D Bioprinting Introduction
11.20.4 Fluicell Revenue in Medical 3D Bioprinting Business (2020-2025)
11.20.5 Fluicell Recent Development
11.21 BigRep
11.21.1 BigRep Company Details
11.21.2 BigRep Business Overview
11.21.3 BigRep Medical 3D Bioprinting Introduction
11.21.4 BigRep Revenue in Medical 3D Bioprinting Business (2020-2025)
11.21.5 BigRep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
3D Systems
GE Healthcare
Exone
Electro Optical Systems
Renishaw
Stratasys Ltd
EnvisionTEC Inc
Cyfuse Biomedical
Formlabs
Organovo Holdings
Allevi
Advanced Solutions
Aspect Biosystems
Cellink AB
GeSIM
Bio3D Technologies
Regenovo Biotechnology
Optomec Inc
Mecuris GmbH
BIGREP
Fluicell
List of Tables
 Table 1. Global Medical 3D Bioprinting Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of SLA
 Table 3. Key Players of FDM
 Table 4. Key Players of LOM
 Table 5. Key Players of Others
 Table 6. Global Medical 3D Bioprinting Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Medical 3D Bioprinting Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Medical 3D Bioprinting Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Medical 3D Bioprinting Market Share by Region (2020-2025)
 Table 10. Global Medical 3D Bioprinting Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Medical 3D Bioprinting Market Share by Region (2026-2031)
 Table 12. Medical 3D Bioprinting Market Trends
 Table 13. Medical 3D Bioprinting Market Drivers
 Table 14. Medical 3D Bioprinting Market Challenges
 Table 15. Medical 3D Bioprinting Market Restraints
 Table 16. Global Medical 3D Bioprinting Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Medical 3D Bioprinting Market Share by Players (2020-2025)
 Table 18. Global Top Medical 3D Bioprinting Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical 3D Bioprinting as of 2024)
 Table 19. Ranking of Global Top Medical 3D Bioprinting Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Medical 3D Bioprinting Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Medical 3D Bioprinting, Headquarters and Area Served
 Table 22. Global Key Players of Medical 3D Bioprinting, Product and Application
 Table 23. Global Key Players of Medical 3D Bioprinting, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Medical 3D Bioprinting Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Medical 3D Bioprinting Revenue Market Share by Type (2020-2025)
 Table 27. Global Medical 3D Bioprinting Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Medical 3D Bioprinting Revenue Market Share by Type (2026-2031)
 Table 29. Global Medical 3D Bioprinting Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Medical 3D Bioprinting Revenue Market Share by Application (2020-2025)
 Table 31. Global Medical 3D Bioprinting Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Medical 3D Bioprinting Revenue Market Share by Application (2026-2031)
 Table 33. North America Medical 3D Bioprinting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Medical 3D Bioprinting Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Medical 3D Bioprinting Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Medical 3D Bioprinting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Medical 3D Bioprinting Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Medical 3D Bioprinting Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Medical 3D Bioprinting Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Medical 3D Bioprinting Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Medical 3D Bioprinting Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Medical 3D Bioprinting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Medical 3D Bioprinting Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medical 3D Bioprinting Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Medical 3D Bioprinting Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Medical 3D Bioprinting Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Medical 3D Bioprinting Market Size by Country (2026-2031) & (US$ Million)
 Table 48. 3D Systems Company Details
 Table 49. 3D Systems Business Overview
 Table 50. 3D Systems Medical 3D Bioprinting Product
 Table 51. 3D Systems Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 52. 3D Systems Recent Development
 Table 53. GE Healthcare Company Details
 Table 54. GE Healthcare Business Overview
 Table 55. GE Healthcare Medical 3D Bioprinting Product
 Table 56. GE Healthcare Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 57. GE Healthcare Recent Development
 Table 58. ExOne Company Details
 Table 59. ExOne Business Overview
 Table 60. ExOne Medical 3D Bioprinting Product
 Table 61. ExOne Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 62. ExOne Recent Development
 Table 63. Electro Optical Systems Company Details
 Table 64. Electro Optical Systems Business Overview
 Table 65. Electro Optical Systems Medical 3D Bioprinting Product
 Table 66. Electro Optical Systems Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 67. Electro Optical Systems Recent Development
 Table 68. Renishaw Company Details
 Table 69. Renishaw Business Overview
 Table 70. Renishaw Medical 3D Bioprinting Product
 Table 71. Renishaw Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 72. Renishaw Recent Development
 Table 73. Stratasys Company Details
 Table 74. Stratasys Business Overview
 Table 75. Stratasys Medical 3D Bioprinting Product
 Table 76. Stratasys Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 77. Stratasys Recent Development
 Table 78. EnvisionTEC Company Details
 Table 79. EnvisionTEC Business Overview
 Table 80. EnvisionTEC Medical 3D Bioprinting Product
 Table 81. EnvisionTEC Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 82. EnvisionTEC Recent Development
 Table 83. Cyfuse Biomedical Company Details
 Table 84. Cyfuse Biomedical Business Overview
 Table 85. Cyfuse Biomedical Medical 3D Bioprinting Product
 Table 86. Cyfuse Biomedical Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 87. Cyfuse Biomedical Recent Development
 Table 88. Formlabs Company Details
 Table 89. Formlabs Business Overview
 Table 90. Formlabs Medical 3D Bioprinting Product
 Table 91. Formlabs Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 92. Formlabs Recent Development
 Table 93. Organovo Holdings Company Details
 Table 94. Organovo Holdings Business Overview
 Table 95. Organovo Holdings Medical 3D Bioprinting Product
 Table 96. Organovo Holdings Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 97. Organovo Holdings Recent Development
 Table 98. Allevi Company Details
 Table 99. Allevi Business Overview
 Table 100. Allevi Medical 3D Bioprinting Product
 Table 101. Allevi Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 102. Allevi Recent Development
 Table 103. Advanced Solutions Company Details
 Table 104. Advanced Solutions Business Overview
 Table 105. Advanced Solutions Medical 3D Bioprinting Product
 Table 106. Advanced Solutions Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 107. Advanced Solutions Recent Development
 Table 108. Aspect Biosystems Company Details
 Table 109. Aspect Biosystems Business Overview
 Table 110. Aspect Biosystems Medical 3D Bioprinting Product
 Table 111. Aspect Biosystems Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 112. Aspect Biosystems Recent Development
 Table 113. CELLINK Company Details
 Table 114. CELLINK Business Overview
 Table 115. CELLINK Medical 3D Bioprinting Product
 Table 116. CELLINK Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 117. CELLINK Recent Development
 Table 118. GeSiM Company Details
 Table 119. GeSiM Business Overview
 Table 120. GeSiM Medical 3D Bioprinting Product
 Table 121. GeSiM Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 122. GeSiM Recent Development
 Table 123. Bio3D Technologies Company Details
 Table 124. Bio3D Technologies Business Overview
 Table 125. Bio3D Technologies Medical 3D Bioprinting Product
 Table 126. Bio3D Technologies Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 127. Bio3D Technologies Recent Development
 Table 128. Regenovo Biotechnology Company Details
 Table 129. Regenovo Biotechnology Business Overview
 Table 130. Regenovo Biotechnology Medical 3D Bioprinting Product
 Table 131. Regenovo Biotechnology Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 132. Regenovo Biotechnology Recent Development
 Table 133. Optomec Company Details
 Table 134. Optomec Business Overview
 Table 135. Optomec Medical 3D Bioprinting Product
 Table 136. Optomec Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 137. Optomec Recent Development
 Table 138. Mecuris Company Details
 Table 139. Mecuris Business Overview
 Table 140. Mecuris Medical 3D Bioprinting Product
 Table 141. Mecuris Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 142. Mecuris Recent Development
 Table 143. Fluicell Company Details
 Table 144. Fluicell Business Overview
 Table 145. Fluicell Medical 3D Bioprinting Product
 Table 146. Fluicell Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 147. Fluicell Recent Development
 Table 148. BigRep Company Details
 Table 149. BigRep Business Overview
 Table 150. BigRep Medical 3D Bioprinting Product
 Table 151. BigRep Revenue in Medical 3D Bioprinting Business (2020-2025) & (US$ Million)
 Table 152. BigRep Recent Development
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Medical 3D Bioprinting Picture
 Figure 2. Global Medical 3D Bioprinting Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medical 3D Bioprinting Market Share by Type: 2024 VS 2031
 Figure 4. SLA Features
 Figure 5. FDM Features
 Figure 6. LOM Features
 Figure 7. Others Features
 Figure 8. Global Medical 3D Bioprinting Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Medical 3D Bioprinting Market Share by Application: 2024 VS 2031
 Figure 10. Medical Device Manufacturers Case Studies
 Figure 11. Pharmaceutical Companies Case Studies
 Figure 12. Others Case Studies
 Figure 13. Medical 3D Bioprinting Report Years Considered
 Figure 14. Global Medical 3D Bioprinting Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Medical 3D Bioprinting Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Medical 3D Bioprinting Market Share by Region: 2024 VS 2031
 Figure 17. Global Medical 3D Bioprinting Market Share by Players in 2024
 Figure 18. Global Top Medical 3D Bioprinting Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical 3D Bioprinting as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Medical 3D Bioprinting Revenue in 2024
 Figure 20. North America Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Medical 3D Bioprinting Market Share by Country (2020-2031)
 Figure 22. United States Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Medical 3D Bioprinting Market Share by Country (2020-2031)
 Figure 26. Germany Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Medical 3D Bioprinting Market Share by Region (2020-2031)
 Figure 34. China Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Medical 3D Bioprinting Market Share by Country (2020-2031)
 Figure 42. Mexico Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Medical 3D Bioprinting Market Share by Country (2020-2031)
 Figure 46. Turkey Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Medical 3D Bioprinting Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. 3D Systems Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 50. GE Healthcare Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 51. ExOne Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 52. Electro Optical Systems Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 53. Renishaw Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 54. Stratasys Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 55. EnvisionTEC Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 56. Cyfuse Biomedical Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 57. Formlabs Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 58. Organovo Holdings Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 59. Allevi Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 60. Advanced Solutions Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 61. Aspect Biosystems Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 62. CELLINK Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 63. GeSiM Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 64. Bio3D Technologies Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 65. Regenovo Biotechnology Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 66. Optomec Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 67. Mecuris Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 68. Fluicell Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 69. BigRep Revenue Growth Rate in Medical 3D Bioprinting Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global 3D Bioprinting in Medical Market Research Report 2024
Global 3D Bio Printers in Medical Market Research Report 2024
Global Bioprinting Market Research Report 2024
Global 3D Cell Culture and 3D Bioprinting Market Research Report 2024
Global Medical 3D Printing Biomaterials Market Research Report 2025
Global Bioprinting Services Market Research Report 2024
Global Inkjet based 3D Bioprinting Market Insights Forecast to 2030
Global 3D Bioprinting Material Market Research Report 2024
Global Laser based 3D Bioprinting Market Insights Forecast to 2030
Global 3D Bioink and Bioprinting Market Research Report 2025
Global Multi Material 3D Bioprinting Market Research Report 2024
Global Tissue Structure 3D Bioprinters Market Research Report 2024
Global 3D Printing Material in Medical Market Research Report 2025
Global 3D Biological Printing Market Insights Forecast to 2030
Global High throughput 3D Bioprinter Market Research Report 2024
Global 3D Bioprinted Human Tissue Market Research Report 2024
Global 3D Bioprinter Market Research Report 2024
Global 3D Bioprinting Software Market Research Report 2024
Global 3D Printing Biomaterials Market Research Report 2025
Global Medical 3D Printing System Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions